Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
2,203 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| NBTX | Nanobiotix S.A. | Healthcare | $2.26B | $44.50 | −22.12% | +17.66% |
| CLOV | Clover Health Investments, Corp. | Healthcare | $2.26B | $4.25 | −23.97% | −1.96% |
| MSB.AX | Mesoblast Limited | Healthcare | $2.25B | 2.45 AUD | −26.13% | +19.85% |
| ADUS | Addus HomeCare Corporation | Healthcare | $2.25B | $120.71 | −3.00% | +1.25% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| URGN | UroGen Pharma Ltd. | Healthcare | $2.25B | $45.94 | −9.58% | +12.38% |
| MESO | Mesoblast Limited | Healthcare | $2.23B | $16.84 | −21.67% | +16.54% |
| PVLA | Palvella Therapeutics, Inc. | Healthcare | $2.22B | $154.33 | −4.37% | +8.04% |
| AUPH | Aurinia Pharmaceuticals Inc. | Healthcare | $2.20B | $16.54 | −14.08% | +10.56% |
| EKTA-B.ST | Elekta AB (publ) | Healthcare | $2.20B | 56.05 SEK | −15.97% | +14.95% |
| MD | Pediatrix Medical Group, Inc. | Healthcare | $2.19B | $26.95 | −3.54% | +0.34% |
| 302440.KS | SK bioscience Co.,Ltd. | Healthcare | $2.18B | 38,100.00 KRW | −37.85% | +17.23% |
| XRAY | DENTSPLY SIRONA Inc. | Healthcare | $2.18B | $10.93 | −26.45% | −18.98% |
| EXE.TO | Extendicare Inc. | Healthcare | $2.18B | 31.68 CAD | −19.06% | −17.40% |
| VCEL | Vericel Corporation | Healthcare | $2.17B | $42.44 | −13.95% | −9.14% |
| 9987.T | Suzuken Co., Ltd. | Healthcare | $2.17B | 5,048.00 JPY | −24.30% | −6.26% |
| HCM.L | HUTCHMED (China) Limited | Healthcare | $2.16B | 179.00 GBP | −32.71% | +3.17% |
| ADMA | ADMA Biologics, Inc. | Healthcare | $2.16B | $9.63 | −52.93% | +9.56% |
| ZBIO | Zenas BioPharma, Inc. | Healthcare | $2.15B | $33.04 | −25.92% | +2.32% |
| ESTA | Establishment Labs Holdings Inc. | Healthcare | $2.15B | $72.45 | −25.76% | −21.16% |
| CLOV34.SA | Clover Health Investments, Corp. | Healthcare | $2.15B | 20.84 BRL | −25.97% | −7.01% |
| HCM | HUTCHMED (China) Limited | Healthcare | $2.15B | $12.35 | −32.51% | +10.27% |
| STOK | Stoke Therapeutics, Inc. | Healthcare | $2.14B | $33.09 | −17.73% | +12.59% |
| GN.CO | GN Store Nord A/S | Healthcare | $2.13B | 94.54 DKK | −23.60% | −2.03% |
| XNCR | Xencor, Inc. Common Stock | Healthcare | $2.11B | $28.44 | −7.09% | +42.41% |
| 008930.KS | Hanmi Science Co., Ltd. | Healthcare | $2.11B | 43,400.00 KRW | −24.52% | +29.36% |
| ZYME | Zymeworks Inc. | Healthcare | $2.10B | $29.31 | −4.29% | +29.61% |
| NVCR | NovoCure Limited | Healthcare | $2.08B | $17.89 | −16.60% | +9.69% |
| ALIF-B.ST | AddLife AB (publ) | Healthcare | $2.08B | 162.30 SEK | −22.12% | +0.87% |
| GNS.L | Genus plc | Healthcare | $2.08B | 2,298.00 GBP | −28.83% | +3.23% |
| GENB | Generate Biomedicines, Inc. | Healthcare | $2.07B | $16.14 | −28.80% | +22.83% |
| SRPT | Sarepta Therapeutics, Inc. | Healthcare | $2.06B | $19.46 | −23.14% | +26.12% |
| NANO.PA | Nanobiotix S.A. | Healthcare | $2.05B | 35.74 EUR | −25.01% | +8.43% |
| PRGO | Perrigo Company plc | Healthcare | $2.05B | $14.76 | −40.02% | +43.30% |
| SEM | Select Medical Holdings Corp | Healthcare | $2.05B | $16.51 | −2.83% | −0.12% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | Healthcare | $2.03B | $33.99 | −26.11% | −5.56% |
| CMPS | COMPASS Pathways plc | Healthcare | $2.02B | $14.61 | −5.13% | +34.65% |
| 6960.T | Fukuda Denshi Co., Ltd. | Healthcare | $2.02B | 11,970.00 JPY | −4.16% | +5.37% |
| GHRS | GH Research PLC | Healthcare | $1.99B | $29.01 | −7.73% | +3.76% |
| VIMIAN.ST | Vimian Group AB (publ) | Healthcare | $1.99B | 35.35 SEK | −1.53% | +1.58% |
| PIII | P3 Health Partners Inc. | Healthcare | $1.98B | $9.92 | −41.27% | −5.70% |
| PGNY | Progyny, Inc. | Healthcare | $1.98B | $26.37 | −20.25% | −14.27% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | Healthcare | $1.98B | 4.82 BRL | −27.74% | +24.55% |
| FLRY3.SA | Fleury S.A. | Healthcare | $1.97B | 18.66 BRL | −5.42% | +9.38% |
| TSHA | Taysha Gene Therapies, Inc. | Healthcare | $1.96B | $6.02 | −17.53% | +10.26% |
| EMBLA.CO | Embla Medical hf. | Healthcare | $1.93B | 30.15 DKK | −20.45% | +5.05% |
| GXE.DE | Lakefront Biotherapeutics NV | Healthcare | $1.93B | 24.68 EUR | −44.50% | +0.82% |
| IMCR | Immunocore Holdings plc | Healthcare | $1.93B | $37.12 | −8.83% | +10.77% |
| ASTH | Astrana Health, Inc. | Healthcare | $1.92B | $38.61 | −25.17% | +1.69% |
| LKFT | Lakefront Biotherapeutics NV | Healthcare | $1.91B | $29.16 | −22.82% | +3.59% |
| SNDA | Sonida Senior Living, Inc. | Healthcare | $1.91B | $39.67 | −10.63% | −7.89% |
| NTLA | Intellia Therapeutics, Inc. | Healthcare | $1.89B | $13.19 | −53.31% | +21.12% |
| DMRA | Damora Therapeutics, Inc. | Healthcare | $1.89B | $30.39 | −20.70% | +3.30% |
| SEPN | Septerna, Inc. | Healthcare | $1.88B | $40.25 | −21.23% | +18.49% |
| NEU.AX | Neuren Pharmaceuticals Limited | Healthcare | $1.88B | 20.59 AUD | −13.34% | +20.20% |
| VIR | Vir Biotechnology, Inc. | Healthcare | $1.87B | $11.08 | −4.97% | +25.20% |
| RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | $1.87B | $3.49 | −51.39% | +14.43% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | Healthcare | $1.84B | 82.40 EUR | −5.72% | +8.42% |
| SGRY | Surgery Partners, Inc. | Healthcare | $1.84B | $14.04 | −40.98% | −9.88% |
| PSNL | Personalis, Inc. | Healthcare | $1.82B | $17.08 | −9.58% | +43.77% |
| BLFS | BioLife Solutions, Inc. | Healthcare | $1.82B | $37.00 | −2.89% | +15.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.